© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cefazolin sodium has roots in the golden age of antibiotic discovery during the late 1960s, a period marked by the hunt for safer, more focused drugs. Chemists drew inspiration from cephalosporins found in seawater near Sardinia, working in labs to amplify and purify their potential. It didn’t take long before pharmaceutical scientists figured out the value in tweaking the cephalosporin backbone, aiming for a stable structure that defeated tough bacteria and didn’t cause as many side effects as older antibiotics. The FDA approved cefazolin in 1973, and it rapidly gained a place among hospital mainstays, especially for surgical infection prevention and serious systemic infections. By then, hospitals were dealing with staph outbreaks, and cefazolin’s reliability made it a favorite for both clinicians and patients. The rollout of this drug led to a dramatic reduction in post-surgical infections and changed how healthcare teams managed surgical wards, making it a workhorse in the heyday of modern antibiotics.
Cefazolin sodium stands out as a first-generation cephalosporin antibiotic, used for preventing and treating a variety of infections. Laboratories produce it as a white to off-white crystalline powder, packaging it in vials for injection. As a broad-spectrum antibiotic, it's especially effective against staphylococci and streptococci. Each vial requires reconstitution before administration, often delivered intravenously or intramuscularly, and the dosing reflects careful calculations balancing infection severity, patient weight, and kidney function. Hospital pharmacies treat it as an essential, with stockrooms holding ample vials, given the high demand for clean, dependable antibiotics in routine surgical suites.
This antibiotic holds its structure as a sodium salt, improving its solubility in water, which becomes crucial during preparation on hospital floors and in clinics. Its molecular weight hovers around 476.5 g/mol, and its chemical formula reads C14H13N8NaO4S3. The powder does not give off an odor, and many technicians remark on how cleanly it dissolves in saline. Stability, though, requires vigilance: high heat can break it down, and improper handling can weaken its effectiveness, so staff learn quickly to spot vials past their prime. Chemists respect its crystalline form, knowing its purity and consistency influence results, whether in lab glassware or injected into a patient.
Cefazolin sodium shows up in sterile vials, typically in strengths of 500 mg, 1 g, or 2 g. The pharmaceutical-grade packaging always features lot numbers, expiry dates, and clear reconstitution instructions to avoid any dosing error. Labels highlight storage temperatures and shine a light on its spectrum of activity. Hospitals anchor inventory tracking software to these details, so every nurse and pharmacist can confirm lot quality within a few mouse clicks. Export guidelines align closely with the World Health Organization’s good manufacturing practices, and product inserts explain the subtle distinctions between administration routes, dosing schedules, and special precautions for people with allergies.
The journey from raw material to finished product starts in fermentation tanks using strains of acremonium or related fungi, which produce the cephalosporin nucleus. Chemists set up a cascade of reactions to attach the specific side chains that define cefazolin’s action. The critical step involves amidation, swinging chemical arms onto the cephalosporin scaffold at just the right spots, followed by the meticulous process of converting it into its sodium salt form. Purification employs crystallization, solvent washes, and filtration, all under strict cleanliness controls. The final dried material gets sealed in airtight vials. Regulatory inspectors watch these processes in real-time, knowing a contaminated or impure lot could have serious consequences in operating rooms around the world.
Cefazolin’s development ushered in an era of extensive side-chain chemistry. Modifying the 7-aminocephalosporanic acid core with a tetrazolyl acetyl side group blocked bacterial enzymes from breaking it apart. The sodium salt swap isn’t just for solubility—it also ensures reliability during storage and rapid action after injection. In labs, researchers continue to cultivate analogues, aiming for new variants that might overcome emerging resistance. Each tweak faces a barrage of stability and effectiveness trials. Some scientists experiment with sustained-release matrices and nano-formulations, driving toward drug delivery that could release Cefazolin slowly and steadily in the body, minimizing spikes and dips in its blood levels.
Pharmaceutical catalogues list cefazolin sodium under several names. Trade names like Ancef and Kefzol dominate in hospitals. The chemical is also called cefazolinum natricum in international texts, and generic labels keep the compound accessible as patents expire. For procurement officers and researchers alike, being able to cross-reference synonyms prevents costly mix-ups and supply shortages.
Handling cefazolin demands a disciplined approach, shaped by decades of shared experience among nurses, pharmacists, and procurement teams. Safety sheets require personal protective equipment during compounding, as direct contact or powder inhalation can trigger allergic responses, especially in those already sensitive to penicillin. Storage areas monitor temperature and humidity, driving home the lesson that only stable drugs should reach patients. Hospitals log every dose dispensed, allowing for accountability if a lot ever prompts a recall. Environmental controls keep particulate matter and other drugs separate during vial filling, defending patients from both cross-contamination and dosage errors.
Cefazolin sodium sees relentless use in surgery wards, holding the frontline in the fight against post-operative infections. It blocks bacteria before they can seize the opportunity presented by surgical incisions, plastic implants, or compromised immune barriers. Surgeons don’t hesitate to call for a vial when cleaning up a clean fracture in the emergency room or prepping a patient for an artificial joint. Internal medicine teams turn to the drug for bloodstream infections and severe skin abscesses, drawing confidence from decades of low resistance rates among target bacteria. Veterinary medicine, recognizing its utility, also taps into cefazolin to protect animal patients in surgery and critical care.
Scientists have not stopped investigating ways to boost cefazolin’s activity. Over the years, research groups published studies on combination therapy, pairing cefazolin with other antimicrobials to punch holes in bacterial defenses. A few teams study structural tweaks, adjusting the side chains and sodium salt ratio for better binding to bacterial targets. Academic labs probe into time-kill curves and minimum inhibitory concentrations, searching for optimal dosing strategies that keep resistance from rising. Pharmaceutical developers run pilot studies on new powder blends, aiming for faster dissolution or improved shelf stability.
Toxicologists walk a careful line when evaluating cefazolin sodium. Animal studies—usually mice, rats, and rabbits—help draw the safety map, spotlighting doses that heal and those that harm. High doses can cause kidney issues and trigger allergic reactions in sensitive people, prompting clear warnings on product inserts. Researchers also keep eyes on off-target effects, like possible disruptions to beneficial gut bacteria or rare blood count changes. Clinical monitoring in hospitals picks up on early warning signs, and electronic records now help connect unexpected side effects to particular drug batches. Real-world use brings data from millions of patients, so adverse effects, though rare, get sorted and reported for global safety updates.
Drug resistance casts a long shadow over every antibiotic, including cefazolin. Researchers worldwide hunt for new ways to outpace evolving bacteria, and cefazolin often serves as a launching pad for next-generation semisynthetic drugs. Some teams experiment with nano-carriers and depot injections that might extend the effective dose in a single shot. Regulatory agencies encourage head-to-head studies of cefazolin versus newer antibiotics, aiming to preserve older drugs for as long as possible. Efforts to slow resistance spread include tighter oversight on hospital prescribing patterns and expanded infection control training. A future path could see cefazolin linked to molecular beacons for infection tracking or formulated as an oral suspension, opening up new options in home care and resource-limited settings.
Cefazolin sodium comes up often in any hospital. This antibiotic handles many of the common bacteria behind infections people pick up in clinics, short- or long-term care facilities, even out in the community. Nurses and doctors count on cefazolin sodium for its ability to act fast against gram-positive bacteria like Staphylococcus and Streptococcus species. For someone who has sat by countless patients’ bedsides, battling everything from infected IV lines to red, swollen surgical wounds, cefazolin’s track record shows up in real results.
Doctors often give cefazolin sodium before surgery to help the body outsmart potential invaders. Surgical tools and open wounds can offer a doorway for bacteria. A dose of cefazolin, delivered right before anesthesia, helps lower the odds that someone will wake up not just sore but fighting a full-blown infection. Without this kind of prevention, hospital-acquired infections could rise. Studies like those in the New England Journal of Medicine report that giving this antibiotic early slashes infection rates, especially for common operations like joint replacements or open-heart procedures.
Not every infection waits for surgery. Skin and soft tissue infections often begin with a minor scrape or bug bite and spiral from there. In patients with diabetes or immune problems, these infections turn dangerous quickly. Cefazolin sodium handles many of the bacteria responsible, providing a reliable choice that won’t overcomplicate things for those who already juggle many medications. In pneumonia, especially when caused by certain bacteria, cefazolin often clears the lungs without causing harsh side effects. For urinary tract, bone, or bloodstream infections where cultures show the bacteria will respond, cefazolin delivers.
Antibiotic resistance keeps changing the chessboard for doctors. Some drugs that once worked no longer do the job. Cefazolin keeps its place partly because bacteria have a harder time building up resistance to it than to newer drugs. It doesn’t have the broadest range, but that actually protects patients. Doctors can fight bacteria without blasting the body’s normal flora, keeping antibiotic stewardship on track. For years, stewardship programs stressed picking focused antibiotics rather than going straight for the big guns. That helps slow resistance in hospitals and in the wider world.
Not every infection listens to cefazolin sodium. If someone’s allergic to penicillins, cross-reactivity with cefazolin could spell trouble. Lab teams need to confirm the infection’s cause before anyone starts or continues treatment. Overuse of any antibiotic—including cefazolin—could speed up resistance. Hospitals need clear rules built from lab data and shared experience to match the right infection to the right medicine.
Better training helps. Medical teams work best when they catch infections early and start antibiotics quickly, then stop them if cultures show another path. Electronic health records can nudge doctors toward evidence-based choices. Even patients play a part. Understanding why certain antibiotics are chosen—and finishing the full course if prescribed—works just as much as the prescription itself.
Cefazolin sodium has earned a respected place in hospitals and clinics. This antibiotic knocks out a wide range of bacteria and offers fast help for people fighting infections. Every medication, though, comes with a few trade-offs. With cefazolin, most folks will tell you that its side effects often show up right away, and healthcare professionals remind us to watch closely.
The gut takes the brunt of many antibiotics, and cefazolin sodium does not always spare your stomach. Nausea, vomiting, and diarrhea don't sound serious until you deal with them — especially on top of already feeling sick. Antibiotics upset the balance of bacteria in your digestive tract, leading to changes that sometimes linger beyond the last dose. Many patients talk about an upset stomach as their main complaint, and studies back this up. In some cases, patients need to stop taking the drug due to severe diarrhea, or they end up with C. difficile infections, which call for urgent treatment.
Penicillin allergies put people on alert when doctors mention cefazolin. Both drugs come from a similar family, so rashes, itchiness, and swelling may appear quickly. More serious allergic reactions pop up with warning signs like trouble breathing or a tight feeling in the chest. A healthcare provider should always be nearby when trying any new antibiotic, but especially in those with a known penicillin allergy. Numbers from the CDC point to about 1-3% of people experiencing some allergic response, and while rare, severe reactions can be life-threatening.
Cefazolin goes into the body through a needle, often in a hospital setting. Some patients talk about pain or redness at the spot where the needle goes in. Nurses who handle these injections day in and day out recognize swelling or firmness around the injection site as part of the routine—but if things get worse or spread, there's reason to check for a deeper infection or vein problem. The skin should never turn dark or feel numb, and any of these symptoms deserve quick medical attention.
Cefazolin can sometimes throw off lab tests, with shifts in blood cell counts and kidney labs. Healthcare workers who watch for these changes might see drops in white blood cell counts or bumps in creatinine. This matters for people with pre-existing kidney trouble or older adults. Someone who struggles with dehydration, or takes other drugs that pressure the kidneys, faces more risk.
Nearly every medication on a hospital tray brings benefits along with risk. People who get cefazolin should let their provider know about any rashes, stomach pain, or change in symptoms right away. It makes sense to have good hydration, pay close attention to stomach issues, and report anything unusual after each dose. Some folks see improvements by taking probiotics, though more research is needed. Doctor-patient conversations, good hand hygiene, and careful monitoring keep most people safe while they get the help they need from cefazolin sodium.
Cefazolin Sodium stands out as a reliable antibiotic, often used during hospital stays for treating various infections. Nurses and doctors don’t pick this drug out of habit—it has a solid track record, especially for skin, bone, joint, and respiratory infections. In my own work shadowing a hospital pharmacist, I watched it get chosen for patients who needed fast, predictable results. These decisions often resulted from discussions among doctors and pharmacists considering the drug’s effectiveness and speed.
Few people realize it, but how you give a medicine can mean the difference between a good recovery and a missed opportunity. With Cefazolin Sodium, pills are out of the question. This antibiotic goes right into the bloodstream, so you’ll see it delivered by intravenous (IV) infusion or deep intramuscular (IM) injection. IV delivery gets the medicine moving fast, which is super important in severe infections or cases where patients can’t swallow or digest well.
Doctors often use IV if patients need large doses or if they’re dealing with a dangerous infection. The IM route shows up more in outpatient clinics or for people who can’t get an IV. I helped with one patient who feared needles, and every effort went into making IM injections less scary—warming the vial and choosing the biggest muscle possible to soothe the sting.
A nurse prepares Cefazolin Sodium as a powder, mixes it with a sterile liquid, and checks the concentration twice. In the hospital, nobody rushes this step. Mistakes here can hit hard, so verifying the right amount for each patient really matters. Some folks need adjustments for kidney issues. In my time working in a ward, kidney checks were routine before setting the dose. It’s an extra step, but skipping it means taking unnecessary risks with toxicity.
Antibiotics often get a reputation for being plug-and-play, but making them work takes skill. The nurse checks blood return before IV administration, flushes the line, and runs the infusion over a specific period to cut down on pain or tissue irritation. It’s all about timing and steady hands, because a rushed job can lead to phlebitis, which nobody — patient or nurse — wants to manage. For IM, nurses stick to large muscles, mostly the gluteus or thigh, to lessen pain and work the medicine deep into the tissue.
Many of the problems with antibiotics like Cefazolin Sodium don’t come from the drug itself but from missteps in how people use it. I’ve seen a few scary close calls when new staff skipped part of the process—doses delayed, or IVs run too quickly. Solid training makes a difference. More hospitals now require checklists and double-check systems to prevent error. Evidence from infection control committees shows fewer complications where staff stick closely to protocols.
Making sure Cefazolin Sodium helps patients really comes down to a team that communicates and supports each other. If a hospital invests in ongoing staff training, it shrinks the risk of dosing problems and side effects. Switching to automated dose checking and barcode scans for each patient is a real step forward that several medical centers have already put in place. Encouraging patients to share how injections and infusions make them feel only helps staff to fine-tune care. If nurses and doctors listen carefully, everyone walks away with less pain and better health outcomes.
Plenty of people depend on antibiotics to fight off infections. Cefazolin Sodium often gets pulled off the shelf in hospitals for everything from skin infections to prepping someone for surgery. Doctors trust this medication because it covers a lot of common bacteria, works quickly, and isn’t a mystery when it comes to dosing. Still, it’s not just about finding an infection and blasting it away. There's more to think about, especially when someone already deals with other health problems or allergies.
Anyone who’s ever had a bad reaction to penicillin or other cephalosporins needs to speak up before starting Cefazolin Sodium. Allergies don’t mess around. Symptoms like hives, itching, swelling, or trouble breathing signal a medical emergency called anaphylaxis. Some folks have open conversations with their doctors and still end up getting surprised by an allergy. People sometimes forget a childhood reaction or think a rash after a dose “wasn’t a big deal.” But the stakes are serious. A medical ID bracelet or an old medical chart can spark an important talk during a rushed ER visit.
Years working with patients have shown how essential kidney checks are with antibiotics. Cefazolin gets flushed out of the body by the kidneys, so someone who already battles with kidney disease or has lost a bit of kidney function walks a finer line. Dosing must change so the drug doesn’t pile up inside the bloodstream. Even people with healthy kidneys can develop issues if they get dehydrated or take other drugs that strain their filters. Some rare cases see liver enzymes go up, which triggers regular blood tests for those already battling liver issues.
Hospital patients often juggle multiple pills. Combining Cefazolin Sodium with certain diuretics or blood thinners can change how the medicine works—or up the risks for side effects. For instance, some blood thinners, like warfarin, can act up, leading to more bleeding. Health workers need up-to-date medication lists, and people with long-term prescriptions can’t afford to be shy at check-in time.
Stories from clinics reveal that antibiotics, powerful as they are, sometimes stir up trouble for the intestines. Cefazolin Sodium can wipe out good bacteria and allow tougher bugs, such as Clostridioides difficile, to take over. Diarrhea can show up days or weeks after stopping. This isn’t just a nuisance. Older adults and those with immune issues run into C. diff more often, and they sometimes end up back in the hospital for it. Proper handwashing, smart antibiotic use, and early reporting of new stomach problems can keep outbreaks at bay.
As someone who’s coached families through infections, I’ve seen how prevention can lighten the antibiotic load. Getting vaccinated and paying attention to hygiene keeps people out of the antibiotic cycle. Prevention isn’t just about dodging infections; it cuts down the need for heavy-hitting drugs like Cefazolin Sodium, which lowers the risk of side effects for the whole community.
Cefazolin Sodium often stands out in hospitals as an injectable antibiotic, prescribed by doctors in emergency rooms and on surgical wards. This drug, part of the cephalosporin family, targets a range of bacterial infections. My personal experience as a health writer has brought me in contact with several clinicians who see Cefazolin as a dependable choice for serious illnesses. Still, everything changes when pregnancy or a new baby enters the picture. Concerns about safety add extra weight to every prescription.
Medical study after medical study tries to answer one question: Will this drug harm the developing baby? Research on Cefazolin offers some reassurance. Decades of use and clinical review indicate that Cefazolin does not seem to raise the risk of birth defects in most situations. The U.S. Food and Drug Administration placed Cefazolin in Category B. For newer medications, this category simply means that animal studies have not shown risk to the fetus, but well-controlled studies on pregnant people remain limited.
Clinical guidelines from major groups like the American College of Obstetricians and Gynecologists suggest that doctors can use Cefazolin during pregnancy if needed. This is not an open invitation to hand it out with every cough, but it shows that, if an infection puts mother or baby at risk, Cefazolin is not off the table. Some conditions force the issue—such as emergency C-sections where protecting against infection can be a matter of life and death. In those moments, the benefits of treatment outweigh any possible risk.
Many women worry about antibiotics in general. Stories shared online often come straight from mothers who faced infection during pregnancy, torn between risking their own health or worrying about the baby. I have spoken with nurses and new mothers in clinics who remember those “what if” questions that pop up at 2 a.m. Their doctors often reviewed decades of data, looked at the specific infection, and explained why Cefazolin was their best bet.
Not every infection needs antibiotics, yet untreated infections can cause complications like preterm labor. The choice to use Cefazolin should always start with a conversation between the patient and doctor. Women deserve to ask questions and get plain answers, not medical jargon.
Once the baby arrives, another issue comes up: drug safety during breastfeeding. Trace amounts of Cefazolin may pass into breast milk, but they tend to be very small. According to LactMed and research out of several major children’s hospitals, no harmful effects in nursing infants have been tied directly to Cefazolin so far.
Pediatricians and pharmacists often look for warning signs—like diarrhea or thrush—but my interviews with lactation consultants show that these rarely come up. Most experts say mothers can keep breastfeeding, unless the baby shows clear signs of trouble. Good communication remains key. If a mother notices something off, reaching out to her healthcare provider can help keep baby safe.
Doctors balance the risks and benefits, but open discussion empowers families to make informed choices. A clear record of allergies, ongoing medications, or past reactions helps the care team avoid problems. If Cefazolin is prescribed, asking about possible side effects and signs to watch makes sense.
No medication is risk-free, but Cefazolin has built up trust within the medical community. Careful use supported by up-to-date research and honest dialogue helps ensure the safety of both mothers and babies.
| Names | |
| Preferred IUPAC name | Sodium (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| Other names |
Ancef Kefzol Cefazoline Cefazolinum Jezacillin |
| Pronunciation | /ˌsɛfəˈzoʊlɪn ˈsoʊdiəm/ |
| Identifiers | |
| CAS Number | “27164-46-1” |
| Beilstein Reference | 3647176 |
| ChEBI | CHEBI:3529 |
| ChEMBL | CHEMBL2107576 |
| ChemSpider | 2760031 |
| DrugBank | DB01327 |
| ECHA InfoCard | 100.043.753 |
| EC Number | 602-338-2 |
| Gmelin Reference | 77020 |
| KEGG | D00260 |
| MeSH | D002446 |
| PubChem CID | 656594 |
| RTECS number | X61760000 |
| UNII | 87D93I0V3Q |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C14H13N8NaO4S3 |
| Molar mass | 476.481 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 0.68 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -2.3 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 2.49 |
| Basicity (pKb) | 2.6 |
| Magnetic susceptibility (χ) | -74.0e-6 cm³/mol |
| Viscosity | Viscous liquid |
| Dipole moment | 3.25 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of Cefazolin Sodium is 489 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | J01DB04 |
| Hazards | |
| Main hazards | May cause allergy or hypersensitivity reactions; can cause irritation to eyes, skin, and respiratory tract. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Not classified as hazardous according to OSHA Hazard Communication Standard (29 CFR 1910.1200). |
| Precautionary statements | Protect from light. Store below 25°C. Keep out of reach of children. |
| Lethal dose or concentration | LD50 (intravenous, mouse): 6200 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse (IV) 2000 mg/kg |
| NIOSH | SE8575000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Cefazolin Sodium: Not established. |
| REL (Recommended) | 1 g |
| IDLH (Immediate danger) | No IDLH established. |
| Related compounds | |
| Related compounds |
Cephalothin Cephapirin Cephaloridine Cephalexin Cefalotin |
